BASEL- Alcon, a division of Novartis AG, said Wednesday that it has acquired Tear Film Innovations, Inc., a privately-held company and manufacturer of the iLux Device, a therapeutic device used to treat Meibomian Gland Dysfunction, a leading cause of dry eye. The iLux Device received 510 clearance from the U.S. Food and Drug Administration in Decem
Novartis International AG/ Alcon Announces Acquisition of Tear Film Innovations, Inc.. Processed and transmitted by West Corporation. *Acquisition further expands Alcon's portfolio of comprehensive solutions for patients with dry eye* Tear Film's iLux Device offers innovative, customizable treatment for Meibomian Gland Dysfunction, a leading cause
Valley Cottage, NY 12/18/2018 Future Market Insights delivers key insights and presents a revised forecast of the global ambulatory surgical centres market for a 10 year period from 2017 to 2027 in the report titled "Ambulatory Surgical Centres Market: Global Industry Analysis 2012 2016 and Opportunity Assessment 2017 2027." The revisio
BASEL- Anji Pharmaceuticals Inc. said that it has licensed pradigastat, an inhibitor of acyl coA: diacylglycerol acyl transferase or DGAT1, from Novartis. Anji has secured rights to pursue new indications for pradigastat, with an initial focus on regulatory approval in China. In exchange, Anji has agreed to make a one-time upfront payment of US $2.
CAMBRIDGE, Mass.& SHANGHAI Anji Pharmaceuticals, Inc. announced today it has licensed pradigastat, an inhibitor of acyl coA: diacylglycerol acyl transferase, from Novartis. Anji has secured rights to pursue new indications for pradigastat, with an initial focus on regulatory approval in China. Anji Pharmaceuticals is a clinical stage company de
Rockville, MD 12/18/2018 Blood cancer diagnostics can be defined as the wide range of screening& diagnosis tests associated with blood cancers such as lymphoma, leukemia and myeloma. Bone marrow examination, blood sample tests, complete blood count tests, flow cytometry, cupping therapy and genetic testing are prominent procedures in the diag
Agency: " Food and Drug Administration, HHS." The Breakthrough Devices Program supersedes and combines elements from FDA's Expedited Access Pathway, which was intended to facilitate the development and expedite review of certain devices that demonstrate the potential to address unmet medical needs, as well as the Priority Review Program, which impl
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company signed a license agreement with Daewoong Pharmaceutical Co., Ltd. for development of BBT-401, the first anti-Pellino-1 compound currently under development for ulcerative colitis treatment. In return, Daewoong...
This report studies the global market size of Pharmacy Benefit Management in key regions like North America, Europe, Asia Pacific, Central& South America and Middle East& Africa, focuses on the consumption of Pharmacy Benefit Management in these regions. The following manufacturers are covered in this report, with sales, revenue, market share for e
Lewes, DE 12/18/2018 Diabetic Foot Ulcer Pipeline Analysis report gives comprehensive insights on the various drugs being developed for the treatment of DFU. The report covers all the drugs that are in various phases of development. The pipeline focuses on novel pharmacologic drugs and regenerative medicines covering, antibodies, stem cell th
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following joint statement by Commissioner Scott Gottlieb and Jeff Shuren, director of the Center for Devices and Radiological Health, on the steps to promote innovations in medical devices that help advance patient safety:. We've taken several steps to enhance
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following statement by Commissioner Scott Gottlieb on the FDA' s 2017 report on declining sales/distribution of antimicrobial drugs for food animals, a reflection of improved antimicrobial stewardship:. "Earlier this year, I announced the FDA' s 2019 Strategi
Among the U.S. Food and Drug Administration s responsibilities are approval and regulation of pharmaceutical drugs. In short, its responsibility is to ensure the safety and effectiveness of drugs. In the performance of this task, FDA officials can make two types of errors statistically known as the type I error and type II error.
A new report issued today by the U.S. Food and Drug Administration shows sales and distribution of medically important antibiotics for use in food animals declined by 33 percent between 2016 and 2017. The report shows that the FDA's prohibition on the use of antibiotics for growth promotion and recent steps by chain restaurants to limit antibiotics
Valley Cottage, NY 12/18/2018 The GCC medical gloves market is estimated to increase from US$ 99.5 Mn in 2016 to US$ 240.8 Mn by 2026, registering a CAGR of 9.2% over the forecast period 2016 2026, according to a latest report titled " GCC Medical Gloves Market: Industry Analysis& Opportunity Assessment, 2016-2026" published by Future Mark
New York, NY 12/18/2018 The global Emergency Room Equipment Market five years cumulative revenue was assessed at US$ 23,036.8 Mn from 2017-2021 according to the market research report, "Global Emergency Room Equipment Market" Size, Share, Growth, Trends, Opportunity, Risks& Forecast, 2017-2026.. The study provides an in-depth analysis of t
Sarasota, FL 12/18/2018 Zion Market Research has published a new report titled "Veterinary Ultrasound Scanners Market by Scanning Technology, by Product Type, and by End-User: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 2024". According to the report, the global veterinary ultrasound scanner market was valued at
Sandoz enters into commercialization and supply agreement for insulin biosimilars, anticipating growing demand as diabetes burden rises. Novartis International AG/ Sandoz enters into commercialization and supply agreement for insulin biosimilars, anticipating growing demand as diabetes burden rises. Processed and transmitted by West Corporation.
New York, NY 12/18/2018 Qyresearchreports include new market research report Global mHealth Applications Market Size, Status and Forecast 2018-2025 to its huge collection of research reports. The study objectives are to present the mHealth Applications development in United States, Europe and China. The key players covered in this study Allsc
LAS VEGAS, California, Dec. 18 HealthInsight issued the following news release:. The HealthInsight Quality Award Program recognizes high-performing health care provider organizations in the states for which HealthInsight serves as the Medicare program's Quality Innovation Network-Quality Improvement Organization contractor.
Valley Cottage, NY 12/18/2018 Global hypercalcemia treatment market revenues are anticipated to reach US$ 9.64 Bn in 2017, up from US$ 7.86 Bn in 2015. U.S. FDA approval of denosumab for treating hypercalcemia of malignancy refractory in 2014 has boosted the use of biophosphonates. North America and Western Europe are among the leading market
Polyethylene film is also used in various applications such as packaging, plastic bags, labels, and has enhanced heat sealing properties. LDPE is used to manufacture thin films, general-purpose films, and high-barrier films.High-density polyethylene is widely used in medical tubing. Due to its low cost, low friction, and chemical resistance propert
New York, NY 12/19/2018 Movement Disorder Market: Overview. Neurological diseases such as Huntington's disease, Parkinson's disease and multiple symptom atrophy continues to propel demand for management of the movement disorders. According to Fact.MR, the global movement disorder market is expected to represent a value of over US$ 1,000 Mn by
New York, NY 12/18/2018 Neonatal Ventilator Market: Introduction. Developed countries such as United States have witnessed a significant growth in preterm births since past decade. In the United States witnessed a 2 percent increase in the preterm birth rate, which is expected to further increase in the coming years.
The New York Health and Hospitals issued the following news release:. NYC Health+ Hospitals/Bellevue announced today that its pilot program to help patients transition to a plant-based diet and healthy lifestyle will launch on January 16, 2019. "Clearly this program is addressing an important need in the community," said William Hicks, CEO of NYC